The Safety and Effectiveness of 524W91
HIV Infections

About this trial
This is an interventional treatment trial for HIV Infections focused on measuring Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Antiviral Agents
Eligibility Criteria
Inclusion Criteria Patients must have: Documented HIV infection. CD4 count >= 200 cells/mm3. No active opportunistic infection. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: Malignancy or other condition that would confound study assessment or interfere with ability to complete the study. Malabsorption syndrome or other gastrointestinal dysfunction that might interfere with gastrointestinal absorption. Concurrent Medication: Excluded on the day of each dose: Antiretrovirals. Any prescription or over-the-counter medication. Alcoholic beverages. Coffee, tea, and other xanthine-containing beverages and foods. Patients with the following prior conditions are excluded: History of hepatitis, pancreatitis, or cardiomyopathy within the past 5 years. Prior Medication: Excluded: Antiretrovirals within 24 hours prior to each dose. Any prescription or over-the-counter medications within 48 hours prior to each dose. Alcoholic beverages within 48 hours prior to each dose. Current alcohol or illicit drug use that may affect patient compliance.
Sites / Locations
- ViRx Inc